Arkadiusz Pisula
Medical University of Silesia(PL)
Publications by Year
Research Areas
Hepatitis C virus research, Liver Disease Diagnosis and Treatment, Hepatitis B Virus Studies, HIV/AIDS drug development and treatment, Systemic Lupus Erythematosus Research
Most-Cited Works
- → Real‐world effectiveness and safety of ombitasvir/paritaprevir/ritonavir ± dasabuvir ± ribavirin in hepatitis C: AMBER study(2016)99 cited
- → Prevalence of HCV genotypes in Poland – the EpiTer study(2016)24 cited
- → Efficacy of HCV treatment in Poland at the turn of the interferon era – the EpiTer study(2016)23 cited
- → Real-World Safety and Efficacy of Ombitasvir/Paritaprevir/Ritonavir/+Dasabuvir±Ribavirin (OBV/PTV/r/+DSV±RBV) Therapy in Recurrent Hepatitis C Virus (HCV) Genotype 1 Infection Post-Liver Transplant: AMBER-CEE Study(2017)16 cited
- → Effect of Peginterferon or Ribavirin Dosing on Efficacy of Therapy With Telaprevir in Treatment-Experienced Patients With Chronic Hepatitis C and Advanced Liver Fibrosis(2015)14 cited
- → Predictors of Hepatic Decompensation during Ombitasvir/Paritaprevir/Ritonavir ± Dasabuvir ± Ribavirin Treatment of Genotype 1 and 4 HCV Infected Patients (Real Life Amber Study)(2016)6 cited
- → Hepatitis C virus (HCV) genotype 1 NS5A resistance-associated variants are associated with advanced liver fibrosis independently of HCV-transmission clusters(2018)6 cited
- → Significant Decrease in the Prevalence of Anxiety and Depression after Hepatitis C Eradication(2022)6 cited
- Recommendations for elastography-based imaging of liver.(2015)
- → HCV resistance-associated substitutions following direct-acting antiviral therapy failure – Real-life data from Poland(2021)4 cited